je.st
news
Galena Biopharma Receives New Coverage from Analysts at Oppenheimer
2013-11-27 00:45:43| Biotech - Topix.net
The firm set an "outperform" rating and a $6.00 price target on the stock. Oppenheimer's price target suggests a potential upside of 63.49% from the stock's previous close.
Tags: coverage
receives
analysts
oppenheimer
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||